Targeted therapy for melanoma: a primer.

Targeted therapy for melanoma: a primer.

Item
http://www.wikidata.org/entity/Q34540273
Genotyping of cutaneous melanoma.The MAPK (ERK) Pathway: Investigational Combinations for the Treatment Of BRAF-Mutated Metastatic Melanoma.Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management.Molecular testing in malignant melanoma.Tissue resources for clinical use and marker studies in melanoma.miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.New treatment approaches in melanoma: current research and clinical prospects.Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011".
P2860

Targeted therapy for melanoma: a primer.

Item
http://www.wikidata.org/entity/Q34540273
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeted therapy for melanoma: a primer.
@ast
Targeted therapy for melanoma: a primer.
@en
Targeted therapy for melanoma: a primer.
@nl
type
label
Targeted therapy for melanoma: a primer.
@ast
Targeted therapy for melanoma: a primer.
@en
Targeted therapy for melanoma: a primer.
@nl
prefLabel
Targeted therapy for melanoma: a primer.
@ast
Targeted therapy for melanoma: a primer.
@en
Targeted therapy for melanoma: a primer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Targeted therapy for melanoma: a primer.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932